Authors: PARRAVICINI C BESTETTI G LAURI E CAPRA M RIDOLFO A SANTAMBROGIO S BERTI E ROSSI E PIZZUTO M MORONI M CORBELLINO M GALLI M

Citation: C. Parravicini et al., SEROEPIDEMIOLOGY OF KAPOSIS-SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) INFECTION IN MILAN, ITALY, Haematologica, 83(5), 1998, pp. 469-469

Authors: TIRELLI U ERRANTE D SANTAROSSA S SPINA M GISSELBRECHT C MAROLLEAU JP KERNEIS Y RIDOLFO A BOTTURA P PAN A DELLEFOGLIE P ROSSI G TAVIO M VACCHER E

Citation: U. Tirelli et al., EPIRUBICIN, BLEOMYCIN, VINBLASTINE AND PREDNISONE (EBVP) CHEMOTHERAPY(CT) IN COMBINATION WITH ANTIRETROVIRAL THERAPY AND PRIMARY USE OF G-CSF FOR PATIENTS (PTS) WITH HODGKINS-DISEASE AND HIV-INFECTION (HD-HIV), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 63-63

Authors: CLERICI M BALOTTA C MERONI L FERRARIO E RIVA C TRABATTONI D RIDOLFO A VILLA M SHEARER GM MORONI M GALLI M

Citation: M. Clerici et al., TYPE-1 CYTOKINE PRODUCTION AND LOW-PREVALENCE OF VIRAL ISOLATION CORRELATE WITH LONG-TERM NONPROGRESSION IN HIV-INFECTION, AIDS research and human retroviruses, 12(11), 1996, pp. 1053-1061

Authors: GORI A CAREDDA F FRANZETTI F RIDOLFO A RUSCONI S MORONI M

Citation: A. Gori et al., REVERSIBLE DIABETES IN PATIENT WITH AIDS-RELATED KAPOSIS-SARCOMA TREATED WITH INTERFERON ALPHA-2A, Lancet, 345(8962), 1995, pp. 1438-1439